Skip to main content
. 2021 May 9;73(8):1524–1527. doi: 10.1093/cid/ciab414

Table 1.

Frequency of Exposure to Multiple antibiotics, a High-Risk Antibiotic, and the Probiotic Among Eligible Inpatients During the Observation and Intervention periods and the Incidence of Healthcare-Associated Clostridioides difficile Infection

Intervention
Antibiotic Types During Hospitalization Observation
(All)
Intervention
(All)
OR (95% CI) No Probiotic Probiotic OR (95% CI)
All patients using antibiotics, no. 5666 8266 2490 5776
 All HA-CDI cases, no. (%) 84 (1.5) 73 (0.9) 0.59 (.43–.81)a 28 (1.1) 45 (0.8) 0.69 (.43– 1.11)
2+ Types
 Patients, no. (%) 3294 (58) 4965 (60) 1.08 (1.01–1.16)a 1100 (44) 3865 (67) 2.6 (2.3–2.8)a
 HA-CDI cases, no. (%) 73 (2.2) 61 (1.2) 0.55 (.39–.77)a 22 (2.0) 39 (1.0) 0.50 (.29–.85)a
3+ Types
 Patients, no. (%) 1362 (24) 2190 (26) 1.14 (1.05–1.23)a 269 (11) 1921 (26) 4.1 (3.6–4.7)a
 HA-CDI cases, no. (%) 52 (3.8) 28 (1.3) 0.33 (.21–.52)a 8 (3.0) 20 (1.0) 0.34 (.15–.79)a
4+ Types
 Patients, no. 419 (7.4) 673 (8.1) 1.11 (.98–1.26) 53 (2.1) 620 (11) 5.5 (4.2–7.3)a
 HA-CDI cases, no. (%) 32 (7.6) 11 (1.6) 0.20 (.10–.40)a 4 (7.5) 7 (1.1) 0.14 (.04–.49)a
Any quinolone
 Patients, no. (%) 1334 (24) 1274 (15) 0.59 (.54–.64)a 281 (11) 993 (17) 1.6 (1.4–1.9)a
 HA-CDI cases, no. (%) 33 (2.5) 13 (1.0) 0.41 (.21–.78)a 5 (1.8) 8 (0.8) 0.45 (.15–1.38)
Any 3rd-generation cephalosporin
 Patients, no. (%) 849 (15) 2211 (27) 2.1 (1.9–2.3)a


372 (15)
1839 (32)
2.7 (2.4–3.0)a
 HA-CDI cases, no. (%) 22 (2.6) 25 (1.1) 0.43 (.24–
0.77)a
7 (1.9) 18 (1.0) 0.52
(.21–1.24)
Any carbapenem
 Patients, no. (%) 336 (6) 464 (6) 0.94 (.82–1.09) 95 (4) 369 (6) 1.7 (1.4–2.2)a
 HA-CDI cases, no. (%) 17 (5.1) 8 (1.7) 0.33 (.14–.77)a 3 (3.2) 5 (1.4) 0.42 (.10–1.79)
Any high-risk antibiotic
 Patients, no. (%) 2277 (40) 3659 (44) 1.2 (1.1–1.3)a 720 (29) 2939 (51) 3.4 (3.1–3.8)a
 HA-CDI cases, no. (%) 57 (2.5) 39 (1.1) 0.42 (.28–.63)a 13 (1.8) 26 (0.9) 0.49 (.28–.63)a

Abbreviations: CI, confidence interval; HA-CDI, healthcare-associated Clostridioides difficile infection; OR, odds ratio.

a Significant at P ≤ .05. Rates and incidences were compared using Fisher exact tests in standard or modified 2-by-2 contingency tables.